/
M Guckenberger - SBRT stage I NSCLC - HICARE 2015
40
• Promising OS considering very advanced age and
malignant disease
OS
Takeda 2013
54 % @ 3a
Sandhu 2013
74 % @ 2a
Haasebeek 2010
45 % @ 3a
Safety & efficacy in elderly patients